Affiliation:
1. Pranveer Singh Institute of Technology Pharmacy Kanpur India
Abstract
Background:
Rheumatoid arthritis affects roughly 5 out of every 1000 persons, rheumatoid
arthritis is a persistent anarchic ailment with complicated pathophysiology a well-known cause
of arthritis-related stinging apropos nexus, degradation of synovium, the creation of pannus, damage
to bones, and loss of the cartilage. Thus, it is imperative to diagnose and treat rheumatoid arthritis.
Due to rheumatoid arthritis's complexity, early diagnosis is difficult, which makes the treatment
difficult. Moreover, anti- rheumatoid arthritis drugs taken on a long-term basis can damage patients'
organs as well. Due to this, these anti- rheumatoid arthritis medications may cause severe side effects
in extra-articular tissues since they cannot selectively target the affected zone. There has been
substantial progress in the discovery of this disease's pathophysiology and treatment strategy over
the past few years, as well as in developing effective diagnostic methods, early detection, and efficient
treatment strategies. In the rheumatoid arthritis, nanotechnology has come to the fore as a
game-changer in effectively managing many diseases. Various nanotechnology approaches are
promising for designing formulations that can deliver drugs to bone and cartilage in targeted and
non-targeted ways like Targeting receptors on inflammation-related cells (CD44, Scavengers receptors,
etc.)
Conclusion:
Nanotechnology is used to treat Rheumatoid arthritis, improve implants and prostheses,
and develop new diagnostic and treatment methods in orthopedic medicine. Many chronic orthopedic
diseases exist, but rheumatoid arthritis is the most common. Several research studies have
found that nanotechnology could deliver targeted drugs, reduce adverse effects on non-target organs,
increase drug concentration in synovial tissues, and slow the progression of immune-mediated
rheumatoid diseases such as rheumatoid arthritis. This review examines how nanotechnology can be
used to diagnose and treat rheumatoid arthritis.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献